JVM, a subsidiary of Hanmi Pharmaceutical, said Friday that it has signed an agreement to supply its automatic tablet distributing and packing system (ATDPS) to OMB, a Russian medical device company.

Under the accord, JVM will begin installing its ATDPS at the Sechenov University Hospital in Moscow and some medical institutions in St. Petersburg.

“Russia has been preparing to introduce a pharmaceutical tracking system since 2020 and is accelerating the establishment of systems and infrastructures,” a company official said. “The introduction of ATDPS in major hospitals in Russia will improve the efficiency of drug tracing and management.”

Hanmi and JVM also plan to use OMB’s network for the automotive market development in Russia.

The companies expect that the ATDPS market will expand if INVITRO, the parent company of OMB and Russia's largest medical diagnostic testing services firm, decides to create preparation factory type pharmacies in different regions linked to testing centers across Russia.

“ATDPS's entry into the Russian market has just begun, but it has a wide range of potential market expansion,” JVM Vice President Kim Sun-kyung said.

ATDPS, which is a representative product of JVM, classifies, distributes and packs medicines automatically in conjunction with the hospital's prescription information delivery system or pharmacy’s computerized system.